Results 11 to 20 of about 10,143,464 (406)

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.

New England Journal of Medicine, 2022
BACKGROUND High triglyceride levels are associated with increased cardiovascular risk, but whether reductions in these levels would lower the incidence of cardiovascular events is uncertain.
Aruna Das Pradhan, R. Glynn, J. Fruchart, Jean G Macfadyen, Elaine Zaharris, Brendan M. Everett, Stuart E. Campbell, Ryu Oshima, P. Amarenco, D. Blom, E. Brinton, R. Eckel, M. Elam, J. Felício, H. Ginsberg, A. Goudev, Shun Ishibashi, Jacob Joseph, T. Kodama, W. Koenig, L. Leiter, A. Lorenzatti, B. Mankovsky, N. Marx, B. Nordestgaard, D. Páll, K. Ray, Raul D. Santos, H. Soran, A. Susekov, M. Tendera, K. Yokote, N. Paynter, J. Buring, P. Libby, P. Ridker   +35 more
semanticscholar   +1 more source

Associations between neighborhood socioeconomic deprivation and severity of depression: Data from the National Health and Nutrition Examination Survey, 2011–2014

SSM: Population Health, 2022
Neighborhood socioeconomic disadvantage may contribute to depression. This study examined associations between neighborhood socioeconomic disadvantage, measured as deprivation, and depression severity within a broadly representative sample of the U.S ...
Sam J. Neally, Kosuke Tamura, Steven D. Langerman, Sophie E. Claudel, Nicole Farmer, Nithya P. Vijayakumar, Kaveri Curlin, Marcus R. Andrews, Joniqua N. Ceasar, Yvonne Baumer, Tiffany M. Powell-Wiley   +10 more
doaj   +1 more source

Prevalence of cardiovascular risk factors in patients with psoriasis.

Central European Journal of Public Health, 2022
OBJECTIVES The main goal of the study was to describe the demographic, epidemiological, clinical and laboratory characteristics of a monitored group of patients with psoriasis to assess the prevalence of cardiovascular comorbidities and to define the ...
Tomáš Kampe, E. Dorko, K. Rimárová, Andrea Houžvičková, J. Baloghová, Zuzana Baranová, Matúš Madleňák, Igor Rohoň   +7 more
semanticscholar   +1 more source

Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools

RMD Open, 2023
Objectives This study aimed to assess the performance of cardiovascular risk (CVR) prediction models reported by European Alliance of Associations for Rheumatology and European Society of Cardiology recommendations to identify high-atherosclerotic CVR ...
Maria G Tektonidou, Petros P Sfikakis, George Konstantonis, George C Drosos   +3 more
doaj   +1 more source

Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association

Circulation, 2022
Cardiovascular disease remains the leading cause of death in patients with diabetes. Cardiovascular disease in diabetes is multifactorial, and control of the cardiovascular risk factors leads to substantial reductions in cardiovascular events.
Joshua J. Joseph, P. Deedwania, Tushar Acharya, D. Aguilar, Deepak L. Bhatt, D. Chyun, Katherine E Di Palo, S. Golden, L. Sperling   +8 more
semanticscholar   +1 more source

Residual cardiovascular risk [PDF]

European Heart Journal Supplements, 2016
Residual cardiovascular risk is often associated with lipid abnormalities, such as atherogenic dyslipidaemia (AD). Dyslipidaemias are one of the determinants of the risk of developing atherosclerotic cardiovascular disease. In addition to low-density lipoprotein (LDL) particles, which are the most atherogenic lipoproteins, other apolipoprotein B ...
FERRARI, Roberto, Catapano, Alberico L.
openaire   +2 more sources

Application of EULAR and European Society of Cardiology recommendations with regard to blood pressure and lipid management in antiphospholipid syndrome

RMD Open, 2023
Background To examine blood pressure (BP) and lipid treatment eligibility in antiphospholipid syndrome (APS) according to European Alliance of Associations for Rheumatology (EULAR) and European Society of Cardiology (ESC) recommendations.Methods ...
Maria G Tektonidou, Petros P Sfikakis, George Konstantonis, George C Drosos   +3 more
doaj   +1 more source

Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events.

New England Journal of Medicine, 2022
BACKGROUND Childhood cardiovascular risk factors predict subclinical adult cardiovascular disease, but links to clinical events are unclear. METHODS In a prospective cohort study involving participants in the International Childhood Cardiovascular ...
D. Jacobs, J. Woo, A. Sinaiko, S. Daniels, Johanna Ikonen, M. Juonala, Noora Kartiosuo, T. Lehtimäki, C. Magnussen, J. Viikari, Nanhua Zhang, L. Bazzano, Trudy L. Burns, R. Prineas, J. Steinberger, E. Urbina, A. Venn, O. Raitakari, T. Dwyer   +18 more
semanticscholar   +1 more source

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.

New England Journal of Medicine, 2022
BACKGROUND Increases in lipid levels and cancers with tofacitinib prompted a trial of major adverse cardiovascular events (MACE) and cancers in patients with rheumatoid arthritis receiving tofacitinib as compared with a tumor necrosis factor (TNF ...
S. Ytterberg, Deepak L. Bhatt, T. Mikuls, G. Koch, R. Fleischmann, J. Rivas, R. Germino, S. Menon, Yanhu Sun, Cunshan Wang, Andrea Shapiro, K. Kanik, C. Connell   +12 more
semanticscholar   +1 more source

Machine learning in precision diabetes care and cardiovascular risk prediction

Cardiovascular Diabetology, 2023
Artificial intelligence and machine learning are driving a paradigm shift in medicine, promising data-driven, personalized solutions for managing diabetes and the excess cardiovascular risk it poses.
E. Oikonomou, Rohan Khera
semanticscholar   +1 more source